Profile | GDS5420 / 231146_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 362.39 | 62 |
GSM1296119 | B_lesional_pre-dose | 235.47 | 55 |
GSM1296076 | C_lesional_pre-dose | 193.94 | 53 |
GSM1296092 | D_lesional_pre-dose | 172.84 | 52 |
GSM1296103 | E_lesional_pre-dose | 290.32 | 59 |
GSM1296078 | F_lesional_pre-dose | 221.76 | 56 |
GSM1296107 | G_lesional_pre-dose | 189.54 | 51 |
GSM1296109 | H_lesional_pre-dose | 163.76 | 48 |
GSM1296080 | I_lesional_pre-dose | 287.42 | 59 |
GSM1296090 | J_lesional_pre-dose | 148.62 | 49 |
GSM1296074 | K_lesional_pre-dose | 180.06 | 53 |
GSM1296111 | L_lesional_pre-dose | 172.5 | 49 |
GSM1296099 | M_lesional_pre-dose | 338.86 | 61 |
GSM1296086 | O_lesional_pre-dose | 132.18 | 47 |
GSM1296117 | P_lesional_pre-dose | 192.17 | 51 |
GSM1296113 | Q_lesional_pre-dose | 264.78 | 56 |
GSM1296096 | R_lesional_pre-dose | 195.14 | 52 |
GSM1296105 | S_lesional_pre-dose | 232.55 | 54 |
GSM1296098 | T_lesional_pre-dose | 453.1 | 66 |
GSM1296101 | U_lesional_pre-dose | 252.69 | 56 |
GSM1296121 | V_lesional_pre-dose | 180.48 | 50 |
GSM1296088 | W_lesional_pre-dose | 155.18 | 49 |
GSM1296082 | X_lesional_pre-dose | 102.76 | 44 |
GSM1296115 | Y_lesional_pre-dose | 105.01 | 41 |
GSM1296084 | Z_lesional_pre-dose | 250.07 | 56 |
GSM1296072 | B_lesional_day8 | 495.95 | 67 |
GSM1296069 | L_lesional_day8 | 142.5 | 44 |
GSM1296071 | P_lesional_day8 | 203.1 | 50 |
GSM1296070 | Y_lesional_day8 | 135.59 | 44 |
GSM1296073 | V_lesional_day8 | 202.13 | 53 |
GSM1296034 | A_lesional_day15 | 487.58 | 66 |
GSM1296041 | G_lesional_day15 | 168.64 | 49 |
GSM1296035 | R_lesional_day15 | 196.76 | 52 |
GSM1296038 | U_lesional_day15 | 199.17 | 52 |
GSM1296047 | B_lesional_day15 | 367.98 | 62 |
GSM1296039 | E_lesional_day15 | 290.65 | 59 |
GSM1296042 | H_lesional_day15 | 197.15 | 51 |
GSM1296043 | L_lesional_day15 | 152.5 | 46 |
GSM1296037 | M_lesional_day15 | 272.05 | 57 |
GSM1296046 | P_lesional_day15 | 169.68 | 48 |
GSM1296044 | Q_lesional_day15 | 206.03 | 51 |
GSM1296045 | Y_lesional_day15 | 261.9 | 55 |
GSM1296025 | C_lesional_day15 | 297.34 | 59 |
GSM1296033 | D_lesional_day15 | 233.46 | 55 |
GSM1296027 | I_lesional_day15 | 332.14 | 62 |
GSM1296032 | J_lesional_day15 | 326.11 | 60 |
GSM1296024 | K_lesional_day15 | 440.33 | 66 |
GSM1296031 | W_lesional_day15 | 133.95 | 45 |
GSM1296028 | X_lesional_day15 | 258.99 | 57 |
GSM1296029 | Z_lesional_day15 | 243.01 | 55 |
GSM1296026 | F_lesional_day15 | 257.56 | 57 |
GSM1296030 | O_lesional_day15 | 161.22 | 51 |
GSM1296040 | S_lesional_day15 | 164.72 | 49 |
GSM1296036 | T_lesional_day15 | 307.47 | 58 |
GSM1296048 | V_lesional_day15 | 230.35 | 54 |
GSM1296059 | A_lesional_day43 | 257.99 | 57 |
GSM1296066 | G_lesional_day43 | 178.52 | 49 |
GSM1296060 | R_lesional_day43 | 221.24 | 54 |
GSM1296063 | U_lesional_day43 | 184.17 | 51 |
GSM1296064 | E_lesional_day43 | 239.63 | 56 |
GSM1296067 | H_lesional_day43 | 198.81 | 50 |
GSM1296062 | M_lesional_day43 | 311.28 | 59 |
GSM1296068 | Q_lesional_day43 | 224.53 | 52 |
GSM1296050 | C_lesional_day43 | 298.73 | 59 |
GSM1296057 | D_lesional_day43 | 333.89 | 60 |
GSM1296052 | I_lesional_day43 | 313.56 | 61 |
GSM1296054 | J_lesional_day43 | 352.24 | 61 |
GSM1296049 | K_lesional_day43 | 327.68 | 61 |
GSM1296055 | W_lesional_day43 | 136.61 | 45 |
GSM1296053 | X_lesional_day43 | 195.93 | 52 |
GSM1296058 | Z_lesional_day43 | 295.83 | 59 |
GSM1296051 | F_lesional_day43 | 196.23 | 53 |
GSM1296056 | O_lesional_day43 | 170.52 | 51 |
GSM1296065 | S_lesional_day43 | 256.63 | 56 |
GSM1296061 | T_lesional_day43 | 342.38 | 61 |
GSM1296095 | A_non-lesional_pre-dose | 212.76 | 54 |
GSM1296120 | B_non-lesional_pre-dose | 199.05 | 51 |
GSM1296077 | C_non-lesional_pre-dose | 344.73 | 62 |
GSM1296093 | D_non-lesional_pre-dose | 250.75 | 55 |
GSM1296104 | E_non-lesional_pre-dose | 187.21 | 51 |
GSM1296079 | F_non-lesional_pre-dose | 282.11 | 59 |
GSM1296108 | G_non-lesional_pre-dose | 108.38 | 41 |
GSM1296110 | H_non-lesional_pre-dose | 204.82 | 51 |
GSM1296081 | I_non-lesional_pre-dose | 256.08 | 57 |
GSM1296091 | J_non-lesional_pre-dose | 192.99 | 53 |
GSM1296075 | K_non-lesional_pre-dose | 171.03 | 51 |
GSM1296112 | L_non-lesional_pre-dose | 254.37 | 54 |
GSM1296100 | M_non-lesional_pre-dose | 233 | 54 |
GSM1296087 | O_non-lesional_pre-dose | 212.33 | 55 |
GSM1296118 | P_non-lesional_pre-dose | 161.43 | 47 |
GSM1296114 | Q_non-lesional_pre-dose | 160.67 | 47 |
GSM1296097 | R_non-lesional_pre-dose | 207.06 | 53 |
GSM1296106 | S_non-lesional_pre-dose | 208.06 | 52 |
GSM1296102 | U_non-lesional_pre-dose | 352.94 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 232.23 | 54 |
GSM1296089 | W_non-lesional_pre-dose | 185.19 | 50 |
GSM1296083 | X_non-lesional_pre-dose | 179.1 | 51 |
GSM1296116 | Y_non-lesional_pre-dose | 185.3 | 49 |
GSM1296085 | Z_non-lesional_pre-dose | 247.7 | 56 |